Viewing Study NCT00566761


Ignite Creation Date: 2025-12-24 @ 12:50 PM
Ignite Modification Date: 2026-02-21 @ 3:44 AM
Study NCT ID: NCT00566761
Status: TERMINATED
Last Update Posted: 2024-05-30
First Post: 2007-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
Sponsor: Asociación para Evitar la Ceguera en México
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Edema View
None Central Retinal Vein Occlusion View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Macular edema View
None central retinal vein occlusion View
None bevacizumab View
None triamcinolone View